Rhopressa Eye Drops, featuring 0.02% Netarsudil, is a once-daily ophthalmic solution designed to lower elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. With a convenient 2.5 mL size, Rhopressa offers an innovative approach to managing eye pressure effectively.
Uses:
-
IOP Reduction: For patients with open-angle glaucoma or ocular hypertension.
-
Pressure Management: Helps prevent vision loss by controlling eye pressure.
Dosage: Instill one drop into the affected eye(s) once daily in the evening, as advised by your eye care professional.
CDC Guidelines:
- Maintain proper hand hygiene before use.
- Avoid contaminating the dropper tip by keeping it away from surfaces and the eye.
Details and Features:
-
Once-Daily Administration: Simplifies treatment regimen for better compliance.
-
Unique Mechanism: Utilizes Netarsudil for effective pressure reduction.
-
Compact Size: 2.5 mL bottle for portability and ease of use.
Mechanism of Action: Netarsudil works by inhibiting Rho kinase, increasing the outflow of aqueous humor through the trabecular meshwork, thereby reducing intraocular pressure.
Directions:
- Wash hands thoroughly.
- Tilt head back and apply one drop into the affected eye(s) in the evening.
- Close the bottle immediately after use.
- Use consistently as prescribed.
Warnings:
- For ophthalmic use only.
- Do not touch the dropper tip to any surface to prevent contamination.
- Monitor for signs of allergic reaction; discontinue use and seek medical attention if necessary.
- Keep out of reach of children.
Side Effects: Possible side effects include:
- Conjunctival redness.
- Mild eye discomfort or irritation.
- Blurred vision immediately after application.
- If severe or persistent symptoms occur, consult your eye care professional promptly.
Rhopressa Eye Drops deliver targeted IOP reduction with a novel mechanism, providing a reliable option for glaucoma and ocular hypertension management.
Skip to content
